Bioadaptor
Showing 1 - 8 of 8
DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of
Not yet recruiting
- Coronary Artery Disease
- DynamX Novolimus-eluting Coronary Bioadaptor System
- (no location specified)
Oct 6, 2023
Coronary Artery Disease, Chronic Total Occlusion of Coronary Artery, Bifurcation of Coronary Artery Trial in Rozzano (DynamX
Recruiting
- Coronary Artery Disease
- +4 more
- DynamX Drug-Eluting Coronary Bioadaptor System
-
Rozzano, ItalyHumanitas Research Hospital
Jul 14, 2022
Coronary Artery Disease Trial in Hong Kong (DynamX Novolimus Eluting Coronary Bioadaptor System)
Active, not recruiting
- Coronary Artery Disease
- DynamX Novolimus Eluting Coronary Bioadaptor System
-
Hong Kong, Kowloon, China
- +3 more
Jan 5, 2022
Coronary Artery Disease Trial (DynamX Bioadaptor)
Not yet recruiting
- Coronary Artery Disease
- DynamX Bioadaptor
- (no location specified)
Aug 2, 2022
Coronary Artery Disease, Ischemic Heart Disease Trial in Sweden (DynamX Bioadaptor, Resolute Onyx)
Recruiting
- Coronary Artery Disease
- Ischemic Heart Disease
- DynamX Bioadaptor
- Resolute Onyx
-
Eskilstuna, Sweden
- +18 more
Jul 18, 2022
Coronary Artery Disease Trial in Antwerp, Milan (Percutaneous Coronary Intervention)
Completed
- Coronary Artery Disease
- Percutaneous Coronary Intervention
-
Antwerp, Belgium
- +1 more
Jul 18, 2022
Coronary Artery Disease Trial in New Zealand (DynamX Sirolimus-eluting Coronary Bioadaptor System)
Completed
- Coronary Artery Disease
- DynamX Sirolimus-eluting Coronary Bioadaptor System
-
Auckland, New Zealand
- +6 more
Apr 23, 2021
Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease Trial in Worldwide (Percutaneous Coronary Intervention)
Active, not recruiting
- Coronary Artery Disease
- +3 more
- Percutaneous Coronary Intervention
-
Antwerp, Belgium
- +35 more
Jul 29, 2022